Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 8/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | CXCR3 | P49682 | 9/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15451208 | 0.80 | TDP1 (0.44) | TDP1MAPK1TSHRKDM4EHTT | |
| SCHEMBL15442583 | 0.75 | KCNH2 (0.55) | TDP1MAPK1TSHRKDM4EHTT | |
| SCHEMBL2894649 | 0.74 | KCNH2 (0.54) | TDP1MAPK1TSHRKDM4EHTT | |
| SCHEMBL24133211 | 0.72 | MAPK1 (0.48) | TDP1MAPK1TSHRKDM4EHTT | |
| SCHEMBL17580644 | 0.72 | MAPK1 (0.48) | TDP1MAPK1TSHRKDM4EHTT | |
| SCHEMBL9984711 | 0.72 | TDP1 (0.50) | TDP1MAPK1TSHRKDM4EHTT | |
| SCHEMBL17710679 | 0.72 | MAPK1 (0.48) | TDP1MAPK1TSHRKDM4EHTT | |
| SCHEMBL9984718 | 0.72 | TDP1 (0.50) | TDP1MAPK1TSHRKDM4EHTT | |
| SCHEMBL15445234 | 0.71 | KCNH2 (0.55) | TDP1MAPK1TSHRKDM4EHTT | |
| SCHEMBL9984712 | 0.71 | KDM4E (0.49) | TDP1MAPK1TSHRKDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9006168-B2 | Odorant composition containing allyl ethers as odorant precursors | HENKEL AG & CO., KGAA (DE) | 2015-04-14 | — | — | US | disclosed |
| US-9006168-B2 | Odorant composition containing allyl ethers as odorant precursors | HENKEL AG & CO., KGAA (DE) | 2015-04-14 | — | — | US | disclosed |
| US-20140030397-A1 | ODORANT COMPOSITION CONTAINING ALLYL ETHERS AS ODORANT PRECURSORS | HENKEL AG & CO. KGAA (DE) | 2014-01-30 | — | — | US | disclosed |
| US-20140030397-A1 | ODORANT COMPOSITION CONTAINING ALLYL ETHERS AS ODORANT PRECURSORS | HENKEL AG & CO. KGAA (DE) | 2014-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140030397-A1 | ODORANT COMPOSITION CONTAINING ALLYL ETHERS AS ODORANT PRECURSORS | CHRM5, OR10J3, CHRM3 | TDP1 4595/4885MAPK1 2558/4885TSHR 917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.